Your Messages Inbox
Your Article Summary
See Latest ArticlesBioMimetic Therapeutics, Inc. Announces Patent Allowance from the United States Patent and Trademark Office for PDGF Compositions Patent; Expanded protection for Augment? Injectable and GEM 21S until 2024
BioMimetic Therapeutics, 01/08/09
BioMimetic Therapeutics, Inc. announced the United States Patent Office has allowed the Company's U.S. patent application No. 11/159,533 titled "Platelet-Derived Growth Factor Compositions and Methods of Use Thereof".
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Abbott Seeks FDA Approval of New Dosage Strengths of SIMCOR
Abbott, 12/11/09
Recombinant Human Erythropoietin, Epogin Injection
Application for Approval of Additional Indication of Chemotherapy-Induced Anemia
Chugai Pharmaceutical Co., 12/08/09
Synthon announces European approvals for Raloxifene
Synthon, 12/08/09
Article Search
Sponsor